You are here: Industry Insights > Gland

News List

Dr Reddy’s launches Ertapenem for Injection in US expresspharma
May 13, 2021
Dr Reddy’s Laboratories announced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of INVANZ (ertapenem for injection) for injection, 1 g/vial approved by the US Food and Drug Administration (USFDA).
Gland Pharma gets US FDA nod for generic Foscarnet Sodium Injection, Single-Dose Bag for Infusion expresspharma
April 25, 2021
Gland Pharma received approval from the United States Food and Drug Administration (US FDA) for generic Foscarnet Sodium Injection, 6000 mg/250 mL (24 mg/mL) Single-Dose Bag for Infusion.
Gland Pharma signs deal with RDIF for 252 million Sputnik V vaccine doses expresspharma
March 17, 2021
Gland Pharma has signed a deal with the Russian Direct Investment Fund (RDIF) to make up to 252 million doses of the Sputnik V COVID-19 vaccine, bringing India’s total production of the shot to at least 352 million.
'Watchful Waiting' Less Likely for Black Prostate Cancer Patients drugs
May 23, 2019
"Watchful waiting" is on the rise overall among U.S. men with low-risk prostate cancer, but black men remain less likely to opt for it, a new study finds.
Divi’s, Gland, Fidelity enter race to buy Orchid Pharma firstwordpharma
March 04, 2019
The Economic Times reported that Divi's Laboratories, Divi’s Laboratories Gland Celsus Bio Chemicals and Fidelity Trading Corporation have shown preliminary interest in taking over Orchid Pharma.